SHENZHEN, China, 29 de agosto de 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” o la “CompañÃa”), que sigue desarrollando sus puntos fuertes en el sector sanitario mundial, ha anunciado que ha iniciado una diligencia debida financiera y legal exhaustiva sobre Bowen Therapeutics…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.